Package 51662-1477-1

Brand: enalaprilat

Generic: enalaprilat
NDC Package

Package Facts

Identity

Package NDC 51662-1477-1
Digits Only 5166214771
Product NDC 51662-1477
Product ID 51662-1477_12044a95-d04f-2681-e063-6394a90af8cc
Description

1 mL in 1 VIAL (51662-1477-1)

Marketing

Marketing Status
Marketed Since 2020-02-01
Brand enalaprilat
Generic enalaprilat
Sample Package No

Linked Drug Pages (1)

ENALAPRILAT ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "12044a95-d04f-2681-e063-6394a90af8cc", "openfda": {"unii": ["GV0O7ES0R3"], "rxcui": ["1729200"], "spl_set_id": ["9d88f915-13dd-5463-e053-2a95a90a09bf"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL (51662-1477-1)", "package_ndc": "51662-1477-1", "marketing_start_date": "20200201"}], "brand_name": "ENALAPRILAT", "product_id": "51662-1477_12044a95-d04f-2681-e063-6394a90af8cc", "dosage_form": "INJECTION", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Decreased Blood Pressure [PE]"], "product_ndc": "51662-1477", "generic_name": "ENALAPRILAT", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ENALAPRILAT", "active_ingredients": [{"name": "ENALAPRILAT", "strength": "1.25 mg/mL"}], "application_number": "ANDA078687", "marketing_category": "ANDA", "marketing_start_date": "20200201", "listing_expiration_date": "20261231"}